Here, we evaluated the effect of progranulin treatment on breast cancer cell secretion by examining the presence of various cytokines in the conditioned media of breast cancer cells treated with progranulin, with or without the sortilin-binding molecule AF38469 [26]. This evidence concerns the gene SORT1 and breast carcinoma.